Incidence and severity of cardiotoxicity in metastatic renal cell carcinoma (RCC) patients treated with targeted therapies.

被引：0
|
作者：
Hall, Philip S.
Witteles, Ronald
Srinivas, Sandy
Harshman, Lauren Christine
机构：
[1] Stanford Univ, Internal Med Residency Program, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Cardiovasc Med, Stanford, CA 94305 USA
[3] Stanford Med Ctr, Stanford, CA USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4610
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of patients with late relapse metastatic renal cell carcinoma treated with targeted therapies.
    Mandalapu, Kamal Kishore
    Matrana, Marc Ryan
    Poosarla, Teja
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Incidence of brain metastases in metastatic renal cell carcinoma in the era of targeted therapies.
    Bowman, Alex
    Le, Tri
    Christie, Alana
    Brugarolas, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] SAFETY EVALUATION OF TARGETED THERAPIES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC)
    Leo, S.
    Chiuri, V. E.
    Accettura, C.
    Pellegrino, A.
    Giampaglia, M.
    Saracino, V
    Petrucelli, L.
    Lorusso, V
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [4] Safety Evaluation of Targeted Therapies in Patients with Metastatic Renal Cell Carcinoma (RCC)
    Leo, S.
    Chiuri, V. E.
    Accettura, C.
    Pellegrino, A.
    Giampaglia, M.
    Saracino, V.
    Petrucelli, L.
    Lorusso, V.
    [J]. ONCOLOGY, 2009, 77 : 150 - 151
  • [5] Comparison of two major prognostic models for patients with metastatic renal cell carcinoma treated in the contemporary era of targeted therapies.
    Crepel, M.
    Escudier, B. J.
    Machiels, J. H.
    Staehler, M. D.
    Ravaud, A.
    Gravis, G.
    Joly, F.
    Chevreau, C.
    Zini, L.
    Lang, H.
    Salomon, L.
    Bigot, P.
    Rigaud, J.
    Patard, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Biasoni, D.
    Testa, I.
    Porcu, L.
    De Braud, F.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (08) : 1227 - 1232
  • [7] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    G Procopio
    E Verzoni
    R Iacovelli
    D Biasoni
    I Testa
    L Porcu
    F De Braud
    [J]. British Journal of Cancer, 2012, 107 : 1227 - 1232
  • [8] Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies
    Santoni, Matteo
    Guerra, Federico
    Conti, Alessandro
    Lucarelli, Alessandra
    Rinaldi, Silvia
    Belvederesi, Laura
    Capucci, Alessandro
    Berardi, Rossana
    [J]. CANCER TREATMENT REVIEWS, 2017, 59 : 123 - 131
  • [9] Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies
    Bastin, Julie
    Werbrouck, Emilie
    Verbiest, Annelies
    Punie, Kevin
    Bechter, Oliver
    Woei-A-Jin, Feng Jung
    Wolter, Pascal
    Wildiers, Hans
    Lerut, Evelyne
    Dumez, Herlinde
    Decallonne, Brigitte
    Clement, Paul
    Vanderschueren, Dirk
    Albersen, Maarten
    Oyen, Raymond
    Schoffski, Patrick
    Beuselinck, Benoit
    [J]. ACTA CLINICA BELGICA, 2019, 74 (03) : 169 - 179
  • [10] Molecular profiles and response among metastatic renal cell carcinoma patients treated with targeted therapies
    Donskov, F.
    Pinto, C. A.
    Predoui, R.
    Kong, F.
    Fox, C.
    Georgsen, J.
    Skaarup, K.
    Perini, R.
    Steiniche, T.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S301 - S301
12345